Use this field to search all clinical research documents.
Clinical Research Resources & Offices
DF/HCC has one of the largest clinical research initiatives in the country, taking a unified approach to approving, activating, monitoring, and supporting the cancer-related clinical trials conducted at our member institutions. For more information, please take a moment to review the functions of each of the 3 distinct clinical research offices below, and continue on to the appropriate destination.
For your convenience there are many ways to find the Policies, Guidance, Forms, Templates, and Resources that you may be looking for. Expand the 'CRS Introduction' section for a walkthrough, or head to one of DF/HCC's three clinical research offices below.
View resources that may be helpful within the Clinical Research Support section of the DF/HCC website.
New to clinical research at DF/HCC, or need a refresher on where to find certain resources? View the New PI and Staff page for more information or for support.
Clinical Research at Dana-Farber/Harvard Cancer Center member institutions is facilitated by way of a unified clinical research effort across all member institutions. There are three offices responsible for coordinating this unified effort: The Research Informatics Operations (RIO), The Office of Data Quality (ODQ), and The Office for Human Research Studies (OHRS).
Although all documents are available in a centralized place via the Protocol Lifecycle, or the Document Library, support for specific clinical research areas, functions, or software used across the Cancer Center can be attained by visiting the corresponding office page. View the common functions for each office below.
We are writing to update you on the status of the clinical research support processes in the DF/HCC Office for Human Research Studies (OHRS). While we all recognize the mission-critical importance of reviewing clinical...
October 03, 2019
– Clinical Trials Research Informatics Office
If you have deposited genomic data into dbGaP, you received an email from the NIH with the subject line: ACTION NEEDED: Update to NIH Access Procedures for Genomic Summary Results. The email requested action by May 1,...